Literature DB >> 9191072

Opioid receptor expression in the rat gastrointestinal tract: a quantitative study with comparison to the brain.

J Fickel1, D Bagnol, S J Watson, H Akil.   

Abstract

The present study was undertaken to analyze the expression of two opioid receptor genes (mu and kappa) in different gastrointestinal regions of the rat. A combination of mRNA quantification and immunohistochemical visualization was used to characterize their expression. Using naive animals, RNA was extracted from tissues and used in RNase protection assays: both receptor mRNAs were expressed in all investigated areas but displayed different expression profiles across the various regions of the digestive tract. Stomach and proximal colon appeared to have the highest expression levels of both receptors, whereas the lowest expression levels were found in the duodenum. Expression levels for both receptors were always lower in the gastrointestinal tract compared to the brain. However, the kappa-receptor expression in the proximal colon represented 40% of the amount found in the brain, which is almost 4 times as high as the respective mu-receptor expression. In contrast to smooth muscle cells, myenteric plexus perikarya of the rat stomach and colon were immunoreactive with antibodies raised against the C-termini of both kappa- and mu-opioid receptors. Numerous nerve fibers were also immunoreactive for both mu- and kappa-receptors and distributed in the longitudinal and circular muscle layers. Small perikarya immunoreactive for mu-receptor were localized around the myenteric plexus and at the submucosal border of the circular muscle, whereas only few perikarya were immunoreactive for the kappa-receptor. We conclude that at least in rat stomach and colon, mu- and kappa-opioid receptors may directly control neuronal communication but seem to have no direct influence on smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9191072     DOI: 10.1016/s0169-328x(96)00266-5

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  26 in total

1.  17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion.

Authors:  Yan Zhang; Dwight A Williams; Saheem A Zaidi; Yunyun Yuan; Amanda Braithwaite; Edward J Bilsky; William L Dewey; Hamid I Akbarali; John M Streicher; Dana E Selley
Journal:  ACS Chem Neurosci       Date:  2016-01-08       Impact factor: 4.418

Review 2.  Opioid-induced bowel dysfunction.

Authors:  Gyanprakash A Ketwaroo; Vivian Cheng; Anthony Lembo
Journal:  Curr Gastroenterol Rep       Date:  2013-09

3.  The impact of tissue fixatives on morphology and antibody-based protein profiling in tissues and cells.

Authors:  Linda Paavilainen; Asa Edvinsson; Anna Asplund; Sophia Hober; Caroline Kampf; Fredrik Pontén; Kenneth Wester
Journal:  J Histochem Cytochem       Date:  2009-11-09       Impact factor: 2.479

Review 4.  Pathophysiology and management of opioid-induced constipation: European expert consensus statement.

Authors:  Adam D Farmer; Asbjørn M Drewes; Giuseppe Chiarioni; Roberto De Giorgio; Tony O'Brien; Bart Morlion; Jan Tack
Journal:  United European Gastroenterol J       Date:  2018-12-14       Impact factor: 4.623

5.  The impact of opiate pain medications and psychoactive drugs on the quality of colon preparation in outpatient colonoscopy.

Authors:  Vladimir M Kushnir; Pavan Bhat; Reena V Chokshi; Alexander Lee; Brian B Borg; Chandra Prakash Gyawali; Gregory S Sayuk
Journal:  Dig Liver Dis       Date:  2013-09-06       Impact factor: 4.088

Review 6.  Opioid-induced bowel dysfunction: epidemiology, pathophysiology, diagnosis, and initial therapeutic approach.

Authors:  Spencer Dorn; Anthony Lembo; Filippo Cremonini
Journal:  Am J Gastroenterol Suppl       Date:  2014-09-10

7.  Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in mice.

Authors:  A D Suchitra; S A Dkhar; D G Shewade; C H Shashindran
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

8.  Antibodies and antisense oligodeoxynucleotides to mu-opioid receptors, selectively block the effects of mu-opioid agonists on intestinal transit and permeability in mice.

Authors:  O Pol; L Valle; P Sánchez-Blázquez; J Garzón; M M Puig
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

9.  Neurochemical features of endomorphin-2-containing neurons in the submucosal plexus of the rat colon.

Authors:  Jun-Ping Li; Ting Zhang; Chang-Jun Gao; Zhen-Zhen Kou; Xu-Wen Jiao; Lian-Xiang Zhang; Zhen-Yu Wu; Zhong-Yi He; Yun-Qing Li
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

10.  Chronic methadone use, poor bowel visualization and failed colonoscopy: a preliminary study.

Authors:  Siddharth Verma; Joshua Fogel; David J Beyda; Brett Bernstein; Vincent Notar-Francesco; Smruti R Mohanty
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.